AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02361853 — intervention group
Intervention type: OTHER
Intervention: Exposure: abundance of Immature neutrophils counts in blood samples
Study NCT01273727 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: intravitreal implant 0.7 mg 6 month duration
Study NCT01273727 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dexamethasone
Description: intravitreal implant 0.7 mg duration 6 months
Study NCT01661660 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: observationnal
Description: Observation during a physical exercise
Study NCT01661660 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: observationnal
Description: Observation during a physical exercise
Study NCT00768716 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Description: 2 x 500 mg by mouth once
Study NCT02553616 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention to Promote Healthy Behaviors
Description: Six individualized sessions (30 minutes each) are delivered to each participant randomized to receive the intervention.
Study NCT01282983 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Fiber
Description: The study consists of 21 days consumption of Orange juice. The volunteers will be instructed to consume 200ml of juice twice a day (1 pack of 200ml at lunch and one at dinner) with 4grams of fiber in each pack.
Study NCT01282983 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The study consists of 21 days consumption of Orange juice. The volunteers will be instructed to consume 200ml of juice twice a day (1 pack of 200ml at lunch and one at dinner) without fiber.
Study NCT02880306 — intervention group
Intervention type: OTHER
Intervention: RA
Description: RA was diagnosed based on the 1987 American College of Rheumatology diagnostic criteria
Study NCT05361083 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: F18CETO
Description: Injection of F18CETO or O15water followed by PET/CT
Study NCT04120064 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cholecalciferol
Description: Large, one time dose of 300,000 IU oral cholecalciferol or daily 5,000 IU oral cholecalciferol
Study NCT04120064 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cholecalciferol
Description: Large, one time dose of 300,000 IU oral cholecalciferol or daily 5,000 IU oral cholecalciferol
Study NCT02316821 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RTA 402
Study NCT02316821 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT05569733 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: simultaneous fluor-18 fluorodeoxyglucose (FDG) positron emission tomography with magnetic resonance imaging (PET/MRI)
Description: All subjects fast at least for 4 hours prior to 18F-FDG injection. 18F-FDG is injected intravenously (150 megabecquerel (MBq)) in standard ambient conditions, supine in a dark, noise free room with eyes and ears open. 18F-FDG PET images are acquired for 20 min on a simultaneous GE Signa 3 Tesla (3T) PET/MR scanner with integrated Time-of-Flight (TOF) (GE Healthcare, Chicago, USA). Simultaneous with the 18F-FDG PET/MR acquisition, zero-echo-time (ZTE) MR data are acquired for attenuation correction and a 3D volumetric T1-weighted BRAVO MR sequence using a vendor supplied high-resolution 8-channel phased array head coil (GE Healthcare, Milwaukee, USA).
Study NCT01950806 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pecan-containing diet
Study NCT01950806 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Nut-free diet
Study NCT02267733 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluzone
Description: Fluzone High-Dose will be administered with a planned booster at 30 days post initial administration
Study NCT03216954 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alcohol
Description: During each arm, subjects will receive doses of alcohol, designed to raise BALs to 0.015 and 0.03 g/dl.
Study NCT03216954 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Alcohol
Description: During each arm, subjects will receive doses of alcohol, designed to raise BALs to 0.015 and 0.03 g/dl.
Study NCT03216954 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebos
Description: Subjects will receive placebo capsules
Study NCT03216954 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: N-acetyl cysteine
Description: Subjects will receive n-acetyl cysteine capsules
Study NCT02941237 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Pulse oximeter
Description: Time taken to measure oxygen saturation.~Completion of usability questionnaire
Study NCT03712228 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Factor XIIa antagonist monoclonal antibody
Description: Factor XIIa antagonist monoclonal antibody for intravenous and subcutaneous use
Study NCT03712228 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Buffer without active ingredient
Study NCT01287780 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Collagen-gentamicin sponge
Description: A 10 by 10 cm sponge consisting of 280 mg collagen and 130 mg gentamicin.Two sponges are inserted during hemiarthroplasty surgery, one in the joint and one underneath the fascia at the time of surgical closure.
Study NCT02405286 — intervention group
Intervention type: OTHER
Intervention: Upper gastrointestinal endoscopy
Description: Upper gastrointestinal endoscopy, if stigmata of recent hemorrhage are seen, varices are either injected with ethanolamine or banded, depending on the clinical setting and availability .
Study NCT03567226 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: WeChat Group
Description: Consenting participants will be randomized to either the intervention or the control arm after successfully wearing an accelerometer for one week. The WeChat Group will be a community forum to share information, encourage each other, and receive communications from the study team. In addition, the study team will disseminate the following information through the group:~1. Daily/Weekly Reminders to exercise~2. Health education materials regarding glaucoma and general health and exercise~3. Motivational content~4. Surveys to gauge what information participants found most interesting and useful to help them exercise
Study NCT03567226 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Counselling
Description: Study participants in the control group will receive a handout telling them to increase walking and will be counseled that walking may be helpful for the eye at the return visit
Study NCT02106026 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Preventive education
Description: The intervention group received education to facilitate successful breastfeeding and symptom management as nipple pain. This was supported by strategies designed to (1) prevent problems associated with breastfeeding (nipple lesions, cracks and mastitis), (2) perform breast-care procedures, (3) strengthen information about the advantages of maternal breastfeeding (nutritional support, importance as food for the baby, availability, post-partum recovery) and (4) provide asepsis and hygiene measures.
Study NCT03153917 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: melatonin and cortisol sampling
Description: The study will take place over 15 days during which the nurses will wear an actigraphic wristband and will fulfill a sleep log. During 3 periods of 24 hours selected during these 15 days, including a 12h day shift (Day 2), a 12h night shift (Day 8) and a rest (Day 13), the participants will collect their urine by 4 to 8 hour periods, note the corresponding urine volumes and for each period, sample a 5 mL tube which will be analyzed later (6-sulfatoxymelatonin and urinary cortisol assays). The subjects will complete questionnaires at the beginning of the study (Horne and Ostberg, Insomnia Severity Index, Epworth, Pichot, Hospital Anxiety and Depression) and the days corresponding to the urine sampling (Karolinska and St Mary Hospital).
Study NCT03365921 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Participants would receive 3 doses of Recombinant Hepatitis E Vaccine (Escherichia Coli) intramuscularly at 0, 1, 6 month.
Description: Participants would receive 3 doses of Recombinant Hepatitis E Vaccine (Escherichia Coli) intramuscularly at 0, 1, 6 month.
Study NCT04279808 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: dilator depth
Description: For soft tissue dilation just after guidewire insertion in central venous catheterization through the right internal jugular vein, investigators will measure the distance between the skin puncture site and outside of anterior wall of the vein with real-time ultrasonography in the measured depth group. Next, practitioner will insert the dilator by the measured length and continue to insert the central venous catheter. For the conventional group as a control group, practitioner will perform the central venous catheterization with a manner used routinely by the practitioner.
Study NCT02462382 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Arthroscopic Rotator Cuff Repair
Description: During arthroscopic rotator cuff surgery, the surgeon inserts a small camera, called an arthroscope, into your shoulder joint. The camera displays pictures on a television screen, and your surgeon uses these images to guide miniature surgical instruments to repair the torn ligament.
Study NCT02462382 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Arthroscopic Rotator Cuff Repair
Description: During arthroscopic rotator cuff surgery, the surgeon inserts a small camera, called an arthroscope, into your shoulder joint. The camera displays pictures on a television screen, and your surgeon uses these images to guide miniature surgical instruments to repair the torn ligament.
Study NCT02462382 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ropivacaine
Description: The study group will receive a pump with study drug attached to a catheter placed into the shoulder area by the anesthesiologist.
Study NCT02462382 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: The control group will receive a pump with saine attached to a catheter placed into the shoulder area by the anesthesiologist.
Study NCT02010970 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Group 1 AZD3293
Description: AZD3293 oral solution
Study NCT02010970 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Group 2 AZD3293
Description: AZD3293 oral solution
Study NCT02010970 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Group 3 AZD3293
Description: AZD3293 oral solution
Study NCT02010970 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Group 1 Itraconazole
Description: itraconazole capsule
Study NCT02010970 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Group 2 Diltiazem
Description: Diltiazem ER tablet
Study NCT02010970 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Group 3 Midazolam
Description: midazolam syrup
Study NCT02536131 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Gut-directed hypnotherapy
Description: relaxation technique with hypnotic induction and suggestions aimed at fostering sense of control, acceptance and calming of bowels.
Study NCT03235765 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: MACROGEN Pan Cancer Panel (Tier 2)
Description: This study will utilize a MACROGEN Pan Cancer Panel (Tier 2), which is a hybrid capture-based NGS assay interrogating the coding regions of 170 cancer-related genes.
Study NCT01435577 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tapentadol
Description: 30 mg per administration, maximum 12 administrations over 48 hours
Study NCT01435577 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Matching Placebo
Description: Maximum 12 administrations over 48 hours
Study NCT01968213 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rucaparib
Description: Oral tablets administered twice daily with 8 oz (240 mL) of water on an empty stomach or with food; 28-day cycles of treatment. Doses should be taken as close to 12 hours apart as possible, preferably at the same times every day. Tablets should be swallowed whole.
Study NCT01968213 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral tablets administered twice daily with 8 oz (240 mL) of water on an empty stomach or with food; 28-day cycles of treatment. Doses should be taken as close to 12 hours apart as possible, preferably at the same times every day. Tablets should be swallowed whole.
Study NCT02957682 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Praluent (Alirocumab)
Study NCT02957682 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Study NCT01509937 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: body bioimpedance spectroscopy device
Description: Name of the device is BCM from Fresenius Medical Care D GmbH
Study NCT01509937 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Device
Description: participants in control arm will not receive BCM measurement.
Study NCT04844996 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Surgical induction of endometriotic explants
Description: Surgical induction of endometriosis was done as: A 5-cm vertical midline incision was made and a distal segment 1 cm in length of the right uterine horn was resected. The segment was split longitudinally, and a 5 X 5 mm piece was sectioned.~This piece of uterine tissue was transplanted without removing the myometrium onto the inner surface of the right abdominal wall with the serosal surface apposed and secured with single nonabsorbable 5-0 polypropylene suture at the middle to the abdominal wall. The abdominal incision was closed in two layers~Drug administration:~Vehicle treatment (1 mL/kg/day saline) was administered orally to the control group with the gavage methodology. Ezetimibe (1 mg/kg/day (Ezetrol®, Merck Sharp Dohme, Istanbul, Turkey) was administered orally with gavage methodology to the rats in the study for 28 days postoperatively
Study NCT04844996 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgical induction of endometriotic explants
Description: Surgical induction of endometriosis was done as: A 5-cm vertical midline incision was made and a distal segment 1 cm in length of the right uterine horn was resected. The segment was split longitudinally, and a 5 X 5 mm piece was sectioned.~This piece of uterine tissue was transplanted without removing the myometrium onto the inner surface of the right abdominal wall with the serosal surface apposed and secured with single nonabsorbable 5-0 polypropylene suture at the middle to the abdominal wall. The abdominal incision was closed in two layers~Drug administration:~Vehicle treatment (1 mL/kg/day saline) was administered orally to the control group with the gavage methodology. Ezetimibe (1 mg/kg/day (Ezetrol®, Merck Sharp Dohme, Istanbul, Turkey) was administered orally with gavage methodology to the rats in the study for 28 days postoperatively
Study NCT01600014 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ingenol mebutate gel, 0.015%
Description: Topical field treatment once daily for 3 consecutive days within a 25 cm2 treatment area on the face or scalp of AKs present or emerging after an initial treatment with ingenol mebutate gel, 0.015%
Study NCT01600014 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle gel
Description: Topical field treatment once daily for 3 consecutive days within a 25 cm2 treatment area on the face or scalp of AKs present or emerging after an initial treatment with ingenol mebutate gel, 0.015%
Study NCT01637675 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 20 mg sildenafil citrate by mouth
Description: 20 mg sildenafil citrate tablets by mouth three times a day for 8 weeks
Study NCT01637675 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sodium tanshinone IIA sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth
Description: sodium Tanshinone IIA sulfonate injection 80 mg diluted with 5% glucose solution(0.9% sodium chloride injection will also be permitted if necessary) 250ml iv drip once a day for 8 weeks,as well as 20mg sildenafil citrate tablets by mouth three times a day for the same duration of treatment
Study NCT02664766 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise training program
Description: Supervised 8-week exercise training program. Aerobic exercise (walking, jogging) of increasing duration at 50-60% HRR, at least two sessions per week. Participants will be recording their daily alcohol consumption. Participants will also undergo three trials of acute exercise (before, at the 4th week and at the 8th week of exercise training) in order to investigate whether exercise training can lead to changes in acute responses to exercise. Each trial involves 30 min of exercise on a cycle ergometer at 50-60% HRR.
Study NCT02682433 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: diagnostic hysteroscopy
Description: Women who were routinely referred to perform diagnostic hysteroscopy. As part of the procedure, clear liquid is inserted into the uterine cavity. After the hysteroscopy, abdominal and vaginal sonar will be performed, and the findings will be recorded and will be compared. Immediately after completion of the office hysteroscopy, two-dimensional and three-dimensional sonar to demonstrate the uterine cavity and its walls will be performed while using the liquid which is left in the uterine cavity. It is important to note that no additional invasive operation will be performed beyond what is necessary to perform hysteroscopy. It should be emphasized that the sonar test will be performed immediately and in the same position as the hysteroscopy test. All procedures will be performed in women clinics or day hospitalization. It should be noted that the medical examinations will not be performed unless there are medical reasons.
Study NCT02682433 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: diagnostic sonar test
Description: Women who were routinely referred to perform diagnostic hysteroscopy. As part of the procedure, clear liquid is inserted into the uterine cavity. After the hysteroscopy, abdominal and vaginal sonar will be performed, and the findings will be recorded and will be compared. Immediately after completion of the office hysteroscopy, two-dimensional and three-dimensional sonar to demonstrate the uterine cavity and its walls will be performed while using the liquid which is left in the uterine cavity. It is important to note that no additional invasive operation will be performed beyond what is necessary to perform hysteroscopy. It should be emphasized that the sonar test will be performed immediately and in the same position as the hysteroscopy test. All procedures will be performed in women clinics or day hospitalization. It should be noted that the medical examinations will not be performed unless there are medical reasons.
Study NCT02913508 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vedolizumab intravenous injection
Description: Vedolizumab intravenous injection
Study NCT02913508 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vedolizumab subcutaneous injection
Description: Vedolizumab subcutaneous injection
Study NCT03659968 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical activity training
Description: brisk walking on treadmill and exercises of muscular strengthening with varying durations and intensities depending on physical capabilities of patients
Study NCT03882216 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: soft tissue augmentation using pouch technique
Description: crestal incision with split thickness flap without vertical releasing incision till the mucogingival line then apply the harvested connective tissue graft through it.
Study NCT03882216 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: soft tissue augmentation using modified pouch technique
Description: tunneling will be done at the pontic site till the mucogingival line then a distant vertical incision near the tunnel at the lining mucosa where the harvested connective tissue graft wll be applied .
Study NCT03697837 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parent Management Training
Description: The online digital parent training (DPT) program consists of 8 self-guided courses that take approximately 10 minutes to complete and include text and animated parent-child simulations. The courses are designed to closely parallel the content of existing evidence-based parent management training approaches that exist in numerous parenting books.
Study NCT03875560 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: IC14
Description: recombinant chimeric anti-human CD14 monoclonal antibody
Study NCT03875560 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Inactive
Study NCT02491619 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: orthodontic decompensation
Description: Evaluation of the correlation between bone thickness and tooth inclination previously and after orthodontic treatment of decompensation due to orthognathic surgery
Study NCT00822861 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TPI ASM8
Description: 4 mg/mL, 1 mg BID for 4 days
Study NCT00822861 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TPI ASM8
Description: 4 mg/mL, 2 mg BID for 4 days
Study NCT00822861 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TPI ASM8
Description: 4 mg/mL, 4 mg BID for 4 days
Study NCT00822861 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TPI ASM8
Description: 4 mg/mL, 8 mg OD for 4 days
Study NCT04608578 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Silver
Description: A serious game to improve mental health in youth